A meta-analysis on a biomedical literature database showed that using TCM in combination with EGFR-TKIs was significantly superior to the use of EGFR-TKI alone in total response rate, quality of life improvement, and one-year survival rate of patients with NSCLC (P < 0.05) [21]. This evidence concerns the gene EGFR and non-small cell lung carcinoma.